Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling

被引：0
作者：
M. Martín
J. C. de la Torre-Montero
S. López-Tarruella
K. Pinilla
A. Casado
S. Fernandez
Y. Jerez
J. Puente
I. Palomero
R. González del Val
M. del Monte-Millan
T. Massarrah
C. Vila
B. García-Paredes
J. A. García-Sáenz
A. Lluch
机构：
[1] Universidad Complutense,Medical Oncology Service, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC, GEICAM
[2] CIBERONC,Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC)
[3] Universidad Pontificia Comillas,Medical Oncology Service, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón
[4] CIBERONC,Medical Oncology Department, Hospital Clínico Universitario
[5] CIBERONC,undefined
[6] Hospital General Universitario Gregorio Marañón,undefined
来源：
Breast Cancer Research and Treatment | 2018年 / 171卷
关键词：
Alopecia; Breast cancer; Docetaxel; Scalp cooling;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：627 / 634
页数：7
相关论文
共 50 条
  • [41] COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer
    Katharina Smetanay
    Philippe Junio
    Manuel Feißt
    Julia Seitz
    Jessica Cecile Hassel
    Luisa Mayer
    Lina Maria Matthies
    Arina Schumann
    André Hennigs
    Jörg Heil
    Christof Sohn
    Dirk Jaeger
    Andreas Schneeweiss
    Frederik Marmé
    Breast Cancer Research and Treatment, 2019, 173 : 135 - 143
  • [42] COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer
    Smetanay, Katharina
    Junio, Philippe
    Feisst, Manuel
    Seitz, Julia
    Hassel, Jessica Cecile
    Mayer, Luisa
    Matthies, Lina Maria
    Schumann, Arina
    Hennigs, Andre
    Heil, Joerg
    Sohn, Christof
    Jaeger, Dirk
    Schneeweiss, Andreas
    Marme, Frederik
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 173 (01) : 135 - 143
  • [43] Patient and nursing staff perspectives on automated scalp cooling (ASC) for chemotherapy-induced alopecia in breast cancer
    Ueberroth, Benjamin E.
    Kosiorek, Heidi E.
    Nafissi, Nellie N.
    Ertz-Archambault, Natalie
    Howland, Allison
    Haddad, Tufia
    Northfelt, Donald W.
    SUPPORTIVE CARE IN CANCER, 2024, 32 (07)
  • [44] Persistent Alopecia in a Breast Cancer Patient Following Taxane Chemotherapy and Adjuvant Endocrine Therapy: Case Report and Review of Post-treatment Hair Loss in Oncology Patients with Breast Cancer
    Werbel, Tyler
    Cohen, Philip R.
    CUREUS, 2018, 10 (07):
  • [45] Clinicopathologic Characteristics and Response to Treatment of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors
    Bhoyrul, Bevin
    Asfour, Leila
    Lutz, Gerhard
    Mitchell, Lorne
    Jerjen, Rebekka
    Sinclair, Rodney D.
    Holmes, Susan
    Chaudhry, Iskander H.
    Harries, Matthew J.
    JAMA DERMATOLOGY, 2021, 157 (11) : 1335 - 1342
  • [46] Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients
    Kluger, N.
    Jacot, W.
    Frouin, E.
    Rigau, V.
    Poujol, S.
    Dereure, O.
    Guillot, B.
    Romieu, G.
    Bessis, D.
    ANNALS OF ONCOLOGY, 2012, 23 (11) : 2879 - 2884
  • [47] Febrile neutropenia incidence and the variable toxicity profile between brand and generic docetaxel in the adjuvant treatment of breast cancer with docetaxel and cyclophosphamide regimen
    Tarcha, Flavia Viecili
    Baccarin, Ana Luisa de Castro
    Barros, Lilian Arruda do Rego
    Alencar, Erika Bushatsky Andrade de
    del Giglio, Auro
    Cruz, Felipe Jose Silva Melo
    EINSTEIN-SAO PAULO, 2023, 21 : eAO0486
  • [48] Effects of Diluent Volume and Administration Time on the Incidence of Anaphylaxis Following Docetaxel Therapy in Breast Cancer
    Ishida, Shigeru
    Masuguchi, Ken
    Kawashiri, Takehiro
    Tsuji, Toshikazu
    Watanabe, Hiroyuki
    Akiyoshi, Sayuri
    Kubo, Makoto
    Masuda, Satohiro
    Egashira, Nobuaki
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2020, 43 (04) : 663 - 668
  • [49] Incidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel
    Martine Berliere
    Florence Dalenc
    Nathalie Malingret
    Anita Vindevogel
    Philippe Piette
    Henry Roche
    Jacques Donnez
    Michel Symann
    Joseph Kerger
    Jean-Pascal Machiels
    BMC Cancer, 8
  • [50] The efficacy and tolerability of scalp cooling in preventing chemotherapy-induced alopecia in patients with breast cancer receiving anthracycline and taxane-based chemotherapy in an Asian setting
    Saad, Marniza
    Chong, Flora Li Tze
    Bustam, Anita Zarina
    Ho, Gwo Fuang
    Malik, Rozita Abdul
    Ishak, Wan Zamaniah Wan
    Phua, Vincent Chee Ee
    Yusof, Mastura Md
    Yap, Ning Yi
    Alip, Adlinda
    INDIAN JOURNAL OF CANCER, 2018, 55 (02) : 157 - 161
12345